SCHEMBL22807963

SCHEMBL22807963

Cc1ccc(N(c2ccc(-c3ccc(-c4ccc(N(c5ccccc5)c5cc6ccccc6c6ccccc56)cc4)cc3)cc2)c2cc3ccccc3c3ccccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 2/20 0.41
TDP1 Q9NUW8 2/20 0.37
CYP1A2 P05177 2/20 0.36
CYP2A6 P11509 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
XBP1 P17861 1/20 0.35
HTT P42858 1/20 0.35
ATM Q13315 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
ADORA2A P29274 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23128255 1.00 GPR84 (0.41) GPR84TDP1CYP1A2CYP2A6NPC1
SCHEMBL23544460 1.00 GPR84 (0.41) GPR84TDP1CYP1A2CYP2A6NPC1
SCHEMBL21919221 1.00 GPR84 (0.41) GPR84TDP1CYP1A2CYP2A6NPC1
SCHEMBL19735354 0.97 GPR84 (0.41) GPR84TDP1CYP1A2CYP2A6NPC1
SCHEMBL12744253 0.97 GPR84 (0.40) GPR84TDP1CYP1A2CYP2A6NPC1
SCHEMBL18055166 0.95 CYP1A2 (0.39) GPR84TDP1CYP1A2CYP2A6HTT
SCHEMBL20173629 0.94 GPR84 (0.38) GPR84TDP1CYP1A2CYP2A6NPC1
SCHEMBL13367415 0.94 GPR84 (0.40) GPR84TDP1CYP1A2CYP2A6NPC1
SCHEMBL12744257 0.94 CYP1A2 (0.38) GPR84TDP1CYP1A2CYP2A6HTT
SCHEMBL2541151 0.92 CYP1A2 (0.41) GPR84TDP1CYP1A2CYP2A6HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10873035-B2 Heterocyclic compound and organic light emitting diode containing same LG CHEM, LTD. 2020-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10873035-B2 Heterocyclic compound and organic light emitting diode containing same CRY1, CRY2, PER2 GPR84 1462/4885TDP1 3627/4885CYP1A2 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.